Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026

Go back to Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026
(NASDAQ: LTRN) Delayed: 3.89 +0.10 (2.64%)
Previous Close $3.79    52 Week High
Open $3.84    52 Week Low
Day High $4.10    P/E N/A 
Day Low $3.77    EPS
Volume 65,573